The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Community Health Systems, Inc. (“Community Health” or “the Company”) CYH for violations of the securities laws.
The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Community Health issued a press release on June 19, 2024, “provid[ing] an update on the planned divestiture of two North Carolina hospitals.” According to the Company, “On June 18, 2024, Novant Health, Inc., a North Carolina non-profit corporation (‘Novant’), informed [Community Health] that Novant has decided not to move forward with the acquisition of two North Carolina hospitals. The transactions were contemplated by an Asset Purchase Agreement dated February 28, 2023 (as amended, the ‘Purchase Agreement’), by and among Novant and certain subsidiaries of the Company.” The Company added, “Novant’s decision follows a ruling by the Fourth Circuit Court of Appeals,” which “issued a temporary injunction blocking the sale to Novant Health, pending final resolution of an appeal by the Federal Trade Commission. The injunction prevented completion of the transaction until the Court of Appeals decides whether to uphold or overturn a previous District Court decision that allowed the sale to proceed.”
If you are a shareholder who suffered a loss, click here to participate.
We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm’s website at www.schallfirm.com, or by email at bschall@schallfirm.com.
The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240801819532/en/
Market News and Data brought to you by Benzinga APIs
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.